These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 2116940)
21. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall. Li H; Gu S; Cao X; Wang Z; She M Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042 [TBL] [Abstract][Full Text] [Related]
22. [Induction of hypercholesterolemia in the rabbit with semisynthetic diets. Changes in the composition of high density lipoproteins]. Sánchez-Muniz FJ; Terpstra AH Rev Esp Fisiol; 1988 Mar; 44(1):45-9. PubMed ID: 3140314 [TBL] [Abstract][Full Text] [Related]
23. [Isolation, purification and characterization of tree shrew serum lipoproteins]. Chen BS; Wang KQ; Wang JM; She MP; Xia RY; Lu YZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Apr; 9(2):135-9. PubMed ID: 2955927 [No Abstract] [Full Text] [Related]
24. [The inhibitory effect of apolipoproteins in HDL on experimental atherosclerosis in rabbits]. Ran BF Zhonghua Bing Li Xue Za Zhi; 1989 Dec; 18(4):257-61. PubMed ID: 2636953 [TBL] [Abstract][Full Text] [Related]
25. Role of apolipoproteins A-I, A-II and C-I in cholesterol efflux from endothelial and smooth muscle cells. Savion N; Kotev-Emeth S Eur Heart J; 1993 Jul; 14(7):930-5. PubMed ID: 8375418 [TBL] [Abstract][Full Text] [Related]
26. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
27. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Jeenah M; Kessling A; Miller N; Humphries S Mol Biol Med; 1990 Jun; 7(3):233-41. PubMed ID: 1977072 [TBL] [Abstract][Full Text] [Related]
28. [The primary study on purification, characterization and function of rabbit serum HDL]. Hu YM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):463-5. PubMed ID: 2534588 [TBL] [Abstract][Full Text] [Related]
29. Effect of HDL on the interaction of hyperlipemic LDL with monkey smooth muscle cells. Bates SR Artery; 1980; 7(4):303-15. PubMed ID: 7213019 [TBL] [Abstract][Full Text] [Related]
30. The differences of serum cholesterol and lipoproteins in animals susceptible and nonsusceptible to atherosclerosis. Wang KQ; Li ZG; Hao QL; He JL; Li XZ; Zhang HZ; Tang JJ; Wu G; Chen BS; Wang JM Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):112-9. PubMed ID: 2123036 [TBL] [Abstract][Full Text] [Related]
31. [Rate of elimination of human high-density lipoproteins after their intravenous administration in rabbits by the loss of alpha- cholesterol and apoprotein A-1]. Polikarpova LI; Teriukova NP; Kalashnikova NM; Oleĭnik IA; Klimov AN Vopr Med Khim; 1984; 30(6):98-101. PubMed ID: 6442042 [TBL] [Abstract][Full Text] [Related]
32. Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand White Rabbit. Carreón-Torres E; Juárez-Meavepeña M; Cardoso-Saldaña G; Gómez CH; Franco M; Fievet C; Luc G; Juárez-Oropeza MA; Pérez-Méndez O Atherosclerosis; 2005 Aug; 181(2):233-40. PubMed ID: 16039276 [TBL] [Abstract][Full Text] [Related]
33. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. Majack RA; Castle CK; Goodman LV; Weisgraber KH; Mahley RW; Shooter EM; Gebicke-Haerter PJ J Cell Biol; 1988 Sep; 107(3):1207-13. PubMed ID: 2458361 [TBL] [Abstract][Full Text] [Related]
34. Effect of oxLDL on the uptake and clearance rate of cholesterol in v-SMC originated from human apoA1 transgenic mice. Zeng Y; Zhao G; Qian J; Wang Z; She M Chin Med J (Engl); 2002 Apr; 115(4):584-8. PubMed ID: 12133304 [TBL] [Abstract][Full Text] [Related]
35. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits. Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416 [TBL] [Abstract][Full Text] [Related]
36. Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits. Lebuffe G; Boullier A; Tailleux A; Delfly B; Dupuis B; Fruchart JC; Duverger N; Emmanuel F; Denefle P; Vallet B; Duriez P Biochem Biophys Res Commun; 1997 Dec; 241(1):205-11. PubMed ID: 9405258 [TBL] [Abstract][Full Text] [Related]
37. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice. Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079 [TBL] [Abstract][Full Text] [Related]
38. [Effect of high density lipoprotein (HDL) on the clearance of intracellular lipids with special reference to the co-effect of nifedipine]. Duan HW Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):73-6. PubMed ID: 1499074 [TBL] [Abstract][Full Text] [Related]
39. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Sviridov D; Pyle L; Fidge N Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of apolipoprotein AI by peripheral tissues of the rooster. A possible mechanism of cellular cholesterol efflux. Blue ML; Ostapchuk P; Gordon JS; Williams DL J Biol Chem; 1982 Sep; 257(18):11151-9. PubMed ID: 6809767 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]